Cabaletta Bio, Inc. (CABA)
0.9361
-0.07
(-7.32%)
USD |
NASDAQ |
Nov 20, 16:00
0.9397
0.00 (0.00%)
After-Hours: 20:00
Cabaletta Bio Total Liabilities (Quarterly) : 52.57M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 52.57M |
| June 30, 2026 | 46.14M |
| March 31, 2026 | 44.84M |
| December 31, 2025 | 58.23M |
| September 30, 2025 | 50.29M |
| June 30, 2025 | 46.02M |
| March 31, 2025 | 43.59M |
| December 31, 2024 | 36.65M |
| September 30, 2024 | 30.17M |
| June 30, 2024 | 17.90M |
| March 31, 2024 | 18.74M |
| December 31, 2023 | 17.45M |
| September 30, 2023 | 12.36M |
| June 30, 2023 | 10.50M |
| March 31, 2023 | 11.80M |
| December 31, 2022 | 12.45M |
| Date | Value |
|---|---|
| September 30, 2022 | 5.801M |
| June 30, 2022 | 6.486M |
| March 31, 2022 | 6.935M |
| December 31, 2021 | 8.38M |
| September 30, 2021 | 6.023M |
| June 30, 2021 | 5.601M |
| March 31, 2021 | 3.969M |
| December 31, 2020 | 5.18M |
| September 30, 2020 | 4.265M |
| June 30, 2020 | 3.263M |
| March 31, 2020 | 3.256M |
| December 31, 2019 | 3.147M |
| September 30, 2019 | 101.02M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 44.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 357.70M |
| Amgen, Inc. | 81.70B |
| Anika Therapeutics, Inc. | 52.02M |
| BioCryst Pharmaceuticals, Inc. | 988.45M |
| Imunon, Inc. | 9.386M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 336.49M |
| Shareholders Equity (Quarterly) | 283.92M |
| Debt to Equity Ratio | 0.0816 |
| Current Ratio | 6.546 |
| Net Debt Paydown Yield | 0.08% |